554 related articles for article (PubMed ID: 23792059)
1. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
[TBL] [Abstract][Full Text] [Related]
2. Clinical differences of early and late-onset myasthenia gravis in 985 patients.
Fan L; Ma S; Yang Y; Yan Z; Li J; Li Z
Neurol Res; 2019 Jan; 41(1):45-51. PubMed ID: 30311866
[No Abstract] [Full Text] [Related]
3. Antititin antibody in early- and late-onset myasthenia gravis.
Szczudlik P; Szyluk B; Lipowska M; Ryniewicz B; Kubiszewska J; Dutkiewicz M; Gilhus NE; Kostera-Pruszczyk A
Acta Neurol Scand; 2014 Oct; 130(4):229-33. PubMed ID: 24947881
[TBL] [Abstract][Full Text] [Related]
4. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the autoimmune regulator gene in patients with autoimmune non-APECED polyendocrinopathies.
Palma A; Gianchecchi E; Palombi M; Luciano R; Di Carlo P; Crinò A; Cappa M; Fierabracci A
Genomics; 2013 Sep; 102(3):163-8. PubMed ID: 23643663
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of late-onset myasthenia gravis.
Zivković SA; Clemens PR; Lacomis D
J Neurol; 2012 Oct; 259(10):2167-71. PubMed ID: 22476514
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of
Seldin MF; Alkhairy OK; Lee AT; Lamb JA; Sussman J; Pirskanen-Matell R; Piehl F; Verschuuren JJGM; Kostera-Pruszczyk A; Szczudlik P; McKee D; Maniaol AH; Harbo HF; Lie BA; Melms A; Garchon HJ; Willcox N; Gregersen PK; Hammarstrom L
Mol Med; 2016 Mar; 21(1):769-781. PubMed ID: 26562150
[TBL] [Abstract][Full Text] [Related]
9. The association of PTPN22 R620W polymorphism is stronger with late-onset AChR-myasthenia gravis in Turkey.
Kaya GA; Coşkun AN; Yılmaz V; Oflazer P; Gülsen-Parman Y; Aysal F; Disci R; Direskeneli H; Marx A; Deymeer F; Saruhan-Direskeneli G
PLoS One; 2014; 9(8):e104760. PubMed ID: 25119822
[TBL] [Abstract][Full Text] [Related]
10. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
11. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis.
Meager A; Wadhwa M; Dilger P; Bird C; Thorpe R; Newsom-Davis J; Willcox N
Clin Exp Immunol; 2003 Apr; 132(1):128-36. PubMed ID: 12653847
[TBL] [Abstract][Full Text] [Related]
12. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].
Suzuki S
Brain Nerve; 2011 Jul; 63(7):705-12. PubMed ID: 21747140
[TBL] [Abstract][Full Text] [Related]
13. A tri-modal distribution of age-of-onset in female patients with myasthenia gravis is associated with the gender-related clinical differences.
Asmail A; Kesler A; Kolb H; Drory VE; Karni A
Int J Neurosci; 2019 Apr; 129(4):313-319. PubMed ID: 30260722
[TBL] [Abstract][Full Text] [Related]
14. Late-onset myasthenia gravis is predisposed to become generalized in the elderly.
Sakai W; Matsui N; Ishida M; Furukawa T; Miyazaki Y; Fujita K; Miyamoto R; Yamamoto N; Sako W; Sato K; Kondo K; Nishida Y; Mitsui T; Izumi Y; Kaji R
eNeurologicalSci; 2016 Mar; 2():17-20. PubMed ID: 29473057
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases.
Zhu Y; Wang B; Hao Y; Zhu R
Front Immunol; 2023; 14():1223322. PubMed ID: 37781409
[TBL] [Abstract][Full Text] [Related]
16. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
[TBL] [Abstract][Full Text] [Related]
17. Do associated auto-antibodies influence the outcome of myasthenia gravis after thymectomy?
Keijzers M; Damoiseaux J; Vigneron A; Bodart N; Kessels A; Dingemans AM; Hochstenbag M; Maessen J; De Baets M
Autoimmunity; 2015; 48(8):552-5. PubMed ID: 26226195
[TBL] [Abstract][Full Text] [Related]
18. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.
Chuang WY; Ströbel P; Bohlender-Willke AL; Rieckmann P; Nix W; Schalke B; Gold R; Opitz A; Klinker E; Inoue M; Müller-Hermelink HK; Saruhan-Direskeneli G; Bugert P; Willcox N; Marx A
J Autoimmun; 2014 Aug; 52():122-9. PubMed ID: 24373506
[TBL] [Abstract][Full Text] [Related]
19. Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.
Saruhan-Direskeneli G; Hughes T; Yilmaz V; Durmus H; Adler A; Alahgholi-Hajibehzad M; Aysal F; Yentür SP; Akalin MA; Dogan O; Marx A; Gülsen-Parman Y; Oflazer P; Deymeer F; Sawalha AH
Clin Immunol; 2016 May; 166-167():81-8. PubMed ID: 27181991
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities in older patients with myasthenia gravis - Comparison between early- and late-onset disease.
Klimiec-Moskal E; Quirke M; Leite MI
Acta Neurol Scand; 2022 Mar; 145(3):371-374. PubMed ID: 34750811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
